...retains United States product rights. part a co-promotion agreement, Bayer HealthCare will contribute its sales and marketing expertise for the first three years following product launch, with the expectation that the two firms will maximize penetration of the product into the United States market.

Bayer HealthCare will commercialize rThrombin in all countries outside the United States, leveraging the company's strong commercial presence in these markets. Bayer HealthCare will be responsible for any required clinical trials and securing regulatory approvals and commercializing the product...

NOTE: All illustrations and photos have been removed from this article.



More articles from BIOTECH Patent News
Genentech obtains United States patent., June 01, 2007
Roche obtains United States patent., June 01, 2007
Pharma Pacific obtains United States patent., June 01, 2007
Bayer obtains United States patent., June 01, 2007
Cayla obtains United States patent., June 01, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.